News
Soligenix’s dusquetide receives US FDA orphan drug designation to treat Behçet's disease: Princeton, New Jersey Tuesday, August 19, 2025, 16:00 Hrs [IST] Soligenix, Inc., a lat ...
Labcorp introduces US FDA approved blood test, Lumipulse pTau-217/Beta Amyloid 42 Ratio for Alzheimer's disease: Burlington, North Carolina Tuesday, August 19, 2025, 14:00 Hrs [IS ...
IQVIA & Veeva Systems announce long-term clinical and commercial partnerships and resolution of all disputes: Research Triangle Park, North Carolina Tuesday, August 19, 2025, 15:0 ...
Accord BioPharma launches Imuldosa prefilled syringes at lowest WAC price among branded biosimilars to Stelara: Raleigh, North Carolina Tuesday, August 19, 2025, 13:00 Hrs [IST] A ...
WuXi Biologics Ireland facility receives EMA approval for commercial manufacturing of innovative biologic: Dundalk, Ireland Tuesday, August 19, 2025, 12:00 Hrs [IST] WuXi Biologic ...
US FDA grants breakthrough therapy designation to Daiichi Sankyo & Merck’s ifinatamab deruxtecan for patients with pretreated extensivestage SCLC: Tokyo Tuesday, August 19, 2025 ...
Valneva’s chikungunya vaccine, Ixchiq receives Health Canada marketing authorization: Saint Herblain, France Tuesday, August 19, 2025, 10:00 Hrs [IST] Valneva SE, a specialty va ...
At its15th general body meeting recently, the Chennai-based Consortium of Indian Pharmaceutical Marketers and Manufacturers Associations (CIPMMA) passed a resolution urging the Union Health Ministry ...
Shardul Nautiyal, Mumbai Tuesday, August 19, 2025, 08:00 Hrs [IST] ...
Shardul Nautiyal, Mumbai Tuesday, August 19, 2025, 08:00 Hrs [IST] ...
Future of Indian healthcare revolves around proactive, tech-driven & people-centric systems: Lovekesh Phasu: Nandita Vijayasimha, Bengaluru Tuesday, August 19, 2025, 08:00 Hrs [IS ...
Delhi DCA issues advisory to chemist associations on misuse of pregabalin & tapentadol formulations: Peethaambaran Kunnathoor, Chennai Tuesday, August 19, 2025, 08:00 Hrs [IST] In ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results